Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2016

Dec 5, 2016

30291_dirs_2016-12-05_8eb3bb3c-6032-499d-ad21-ed64f4bac948.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2016-12-01

Reporting Person: COVINO GREGORY F (VP, Chief Accounting Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-12-01 Common Stock A 930 Acquired 3936.8231 Direct
2016-12-01 Common Stock F 53 $295.78 Disposed 3883.8231 Direct